Atlas FDA

Optimum Infinite (tisilfocon A) Orthokeratology Lenses II

FDA premarket approval P240045 · decided 2026-02-10

Approval details

PMA number
P240045
Trade name
Optimum Infinite (tisilfocon A) Orthokeratology Lenses II
Generic name
Lens, contact, orthokeratology, overnight
Applicant
Contamac, Ltd.
Date received
2024-12-17
Decision date
2026-02-10
Days to decision
420 days
Decision code
APPR
Product code
NUU
Advisory committee
Ophthalmic
Expedited review
No
Location
Saffron Walden
Statement
Approval for Optimum Infinite (tisilfocon A) Ortho-k Lenses, Optimum Infinite (tisilfocon A) Orthokeratology Lenses II.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Optimum Infinite (tisilfocon A) Daily Wear Contact Lenses (K212631)Contamac, Ltd.2022-03-17
Hyper GP (tisilfocon A) Daily Wear Contact Lens (K182304)Contamac, Ltd.2018-11-23
Nutrifill (K181566)Contamac, Ltd.2018-10-22
OPTIMUM GP (roflufocon D, roflurocon E) Daily Wear Contact Lens, HEXA100 (hexafocon A) Daily Wear Contact Lens (K180616)Contamac, Ltd.2018-04-25
ENFLU 18 (enflufocon A) Daily Wear Contact Lens (K171575)Contamac, Ltd.2017-10-24
HEXA100 (hexafocon A) Daily Wear Contact Lenses (K171077)Contamac, Ltd.2017-08-01
Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses (K161100)Contamac, Ltd.2016-08-10
OPTIMUM GP OK Daily Wear Contact Lens (roflufocon D & E) (K160859)Contamac, Ltd.2016-07-13